Cart
sales@molnova.com
p-Hydroxy-5,6-dehydrokawain
CAS No. 39986-86-2
p-Hydroxy-5,6-dehydrokawain( 4'-Hydroxydehydrokawain )
Catalog No. M29207 CAS No. 39986-86-2
p-Hydroxy-5,6-dehydrokawain is isolated from Kawain.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 523 | In Stock |
|
| 5MG | 513 | In Stock |
|
| 10MG | 740 | In Stock |
|
| 25MG | 1121 | In Stock |
|
| 50MG | 1507 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Namep-Hydroxy-5,6-dehydrokawain
-
NoteResearch use only, not for human use.
-
Brief Descriptionp-Hydroxy-5,6-dehydrokawain is isolated from Kawain.
-
Descriptionp-Hydroxy-5,6-dehydrokawain is isolated from Kawain.(In Vitro):p-Hydroxy-5,6-dehydrokawain showed significant antiproliferative activity against murine colon 26-L5 carcinoma (ED50: 12.8 μM) and human HT-1080 fibrosarcoma (ED50: 20.1 μM) cells.
-
In Vitro——
-
In Vivo——
-
Synonyms4'-Hydroxydehydrokawain
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number39986-86-2
-
Formula Weight244.246
-
Molecular FormulaC14H12O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOc1cc(\C=C\c2ccc(O)cc2)oc(=O)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
[Tyr8] Bradykinin
[Tyr8] Bradykinin is a B2 kinin receptor agonist. [Tyr8] Bradykinin also stimulates ERK1/2 phosphorylation. [Tyr8] Bradykinin can be used as an internal standard.
-
PXS-5153A
PXS-5153A is an effective, selective, and fast-acting inhibitor of lysyl oxidase like 2/3 enzymes with enzymatic activity almost entirely blocked within 15 minutes. PXS-5153A could reduce crosslinks and ameliorates fibrosis.
-
Clanfenur
Clanfenur belongs to a new group of substituted benzoylphenylureas. The drug shows both in vitro and in vivo antitumour activity.
